Federal Supply Schedule 36F79724D0065

Orphalan LIMITED, identified by Unique Entity Identifier (UEI) UYLAZGRTK356, was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. This indefinite delivery/indefinite quantity (IDIQ) contract was awarded on June 15, 2024, with a ceiling value of $225,000 and an ultimate completion date of June 14, 2029. The contract encompasses the procurement of drugs, pharmaceuticals, and hematology-related products classified under Federal Supply Classification (FSC) 65 I B, with pricing aligned to the 2026 Public Law pricing updates requirements. No set-aside provisions were utilized in this award, and the contract operates as part of the General Services Administration's standard Federal Supply Schedule program structure.

Under this contract vehicle, Orphalan LIMITED will supply pharmaceutical and hematology products to support the healthcare delivery needs of the Veterans Health Administration through VISN 12, which serves the veteran population across its designated service region. The five-year term provides flexibility through the indefinite delivery mechanism to accommodate variable ordering patterns and ensure continuous availability of critical pharmaceutical supplies. As a multiple-award schedule contract, the government maintains the ability to issue task orders or purchase orders against this ceiling value as operational requirements and clinical needs dictate, with pricing established according to the negotiated terms and Public Law mandates for pharmaceutical pricing transparency and updates.